VYGORIS LIMITED

Company number 10259085 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£3,932,938

Balance sheet as at 2025-09-30

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2016-06-30
Employees
4 (2025 accounts)
Registered office
930 High Road, London, United Kingdom, N12 9RT
Postcode
N12 9RT
Capital
2,421,126 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-09-30
Next due by
2027-06-30
Financial year end
30 September

Confirmation statement

Last statement dated
2026-10-01
Next due by
2027-10-15
View filing history →

Nature of business (SIC)

  • 82990 Other business support service activities not elsewhere classified

Officers 1 current · 4 resigned

Subscribers only Director
Subscribers only Appointed 2016-10-02

View all officers and resignations →

Group structure

Controlled by Substipharm Developpement (48006438) — since 2016-07-01

From persons-with-significant-control filings on the public register.

Contact details

Website
vygoris.com

Vygoris is a new company in the UK. We develop, acquire and market sophisticated niche pharmaceutical products. Vygoris is a young, dynamic and vibrant company. We are driven by our ambition to deliver results - results for patients and the scientific community, results for nurses,

Previous company names

NameDate changed
SUBSTIPHARM LIMITED2017-09-29

Previous registered addresses 1

AddressChanged on
SUITE 3 4TH FLOOR, 1 DUCHESS STREET, LONDON, W1W 6AN, UNITED KINGDOM2016-12-08

At this address

Among the biggest employers

of 2,630 similar companies in N, with 4 staff.

Competitors London

This company ranks 4417 among other business support service activities not elsewhere classified in London.

Full league table →

The class of 2016

19%

of the 49,251 companies in this sector incorporated in 2016 are still active today; 77% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →